Clinical trial
A Prospective, Multicenter, Randomized Clinical Trial to Evaluate the Safety and Efficacy of Intravascular Hypothermia Therapy of Patients With Acute Ischemic Stroke
NCT04695236 is registered in ClinicalTrials.gov with jiaoliqun as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Multicenter, Randomized Clinical Trial to Evaluate the Safety and Efficacy of Intravascular Hypothermia Therapy of Patients With Acute Ischemic Stroke
- Lead sponsor
- jiaoliqun
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- December 31, 2020
- Completion date
- December 31, 2022
- Enrollment
- 80 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hypothermia, ischemic stroke, reperfusion injury, thrombectomy